Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00167388 · ClinicalTrials.gov registry record · Phase 1
The Effect of Blood Transfusion on Blood Flow to the Intestines of Premature Infants
A Phase 1 study of Anemia of Prematurity, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT00167388 is a Phase 1 study of Anemia of Prematurity that has completed, run by University of Pittsburgh. The registered enrollment target is 22 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00167388, a Phase 1 study of Anemia of Prematurity, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to see if a blood transfusion changes how fast blood flows to the intestines of a premature baby. Blood flow is measured by an ultrasound test. The investigators also look to see if the blood flow to the intestines depends on whether the baby feeds or doesn't feed during the blood transfusion.
Conditions Studied
Interventions
- OTHER feed during blood transfusion
Study Locations (1)
Pennsylvania
- Magee-Womens Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2005-09 |
| Est. Completion | 2006-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00167388
The ClinicalTrials.gov registry entry for NCT00167388 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anemia of Prematurity appearing as the primary indexed condition, and to 1 intervention - of which feed during blood transfusion is the first listed.
NCT00167388 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00167388 about?
NCT00167388 is a clinical study titled "The Effect of Blood Transfusion on Blood Flow to the Intestines of Premature Infants". The purpose of the study is to see if a blood transfusion changes how fast blood flows to the intestines of a premature baby. Blood flow is measured by an ultrasound test. The investigators also look to see if the blood flow to the intestines depends on whether the baby feeds or doesn't feed during ...
What is the current status of trial NCT00167388?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2005-09. Estimated completion is 2006-11.
What conditions does trial NCT00167388 study?
This clinical trial studies the following conditions: Anemia of Prematurity.
What interventions are being tested in trial NCT00167388?
The interventions under investigation include: feed during blood transfusion (OTHER).
Who is sponsoring clinical trial NCT00167388?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00167388 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia of Prematurity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.